Amarin Corp Plc (AMRN)

[the_kube]

AMRN reported a net loss of GAAP 4 cents per share and positive cash flow. When I look at non-GAAP, they are at a net positive of 2 cents per share.

1) Does anyone foresee positive sales revenue growth for Q3 and Q4?
2) Does anyone foresee further restructuring charges? Q2 charges amounted to 6 cents per share?
3) Are expenses associated with special items (that started showing up in Q1) associated with the proxy fight?
4) With an additional 40 million per year in cost reductions, when does AMRN start reporting positive EPS (GAAP)?

Based on what I see in the Q2 income statement…

Negative - Revenue is declining (likely due to pricing pressure)
Positive - There were a lot of special items dragging down the EPS. I suspect special items and restructuring charges to abate in future quarters.
Positive - Margins are relatively stable thanks to CoGS reductions.

If AMRN can reverse the revenue slide by selling more units, I see potential improvements in share price based on organic activity.

While AMRN has some great IP and a great product, it hasn’t exhibited a strong or steady growth trajectory. Based on this, I suspect the BP BO option is probably not on the table for the foreseeable future.

IMHO